Log in Open CFD Account
[Premium Users]
Client Referral Program Affiliate White Label
Log in Open CFD Account

Stock in News – Tesla and Amazon

20 November 2020 By Deepta Bolaky

Share

Tesla Inc

Tesla Inc, the electric car maker is set to join the S&P500 on December 21. The Company’s share price rallied following the announcement, highlighting the dominance of mega-cap growth stocks on the S&P500 benchmark. The Company also received a trading upgrade to a buy-equivalent citing “the company on the verge of a profound shift” from Morgan Stanley after its debut declaration.

The Company reached an all-time high of $508.61 before retreating lower to close at 499.27 on Thursday following the growing optimism about the future of electric cars.


Source: Bloomberg Terminal

Tesla’s share price rose from a low of $72.24 in March to a high of $508.61 earlier this week. In what is an impressive rally, the rise of the electric car maker goes beyond the fundamentals and has outshined its peers.


Source: Bloomberg Terminal

On the technical side, while the Company’s share price is poised to experience its best week since August, it is navigating near overbought territory.

The Amazon Pharmacy

Another big tech company making headlines this week is Amazon Inc. with the launch of its online pharmacy. The Amazon Pharmacy is a game-changer for the online retailer giant as it will allow customers to order medication or prescription refills to be delivered to their front door within days. Its emergence in the prescription drug space will definitely have some impact on drugstores. The share price of its rival companies CVS Health Corp, Wallgreens Boots Alliance Inc, Rite Aid and GoodRx took a blow on the launch.

Disclaimer: Articles are from Encrypt Investment analysts and contributors and are based on their independent analysis or personal experiences. Views, opinions or trading styles expressed are their own, and should not be taken as either representative of or shared by Encrypt Investment. Advice, if any, is of a ‘general’ nature and not based on your personal objectives, financial situation or needs. Consider how appropriate the advice, if any, is to your objectives, financial situation and needs, before acting on the advice. If the advice relates to acquiring a particular financial product, you should obtain and consider the Product Disclosure Statement (PDS) and Financial Services Guide (FSG) for that product before making any decisions.